Category

Research Archives

TIGM receives EPA funding

July 31, 2009

The Texas A&M Institute for Genomic Medicine (TIGM) – a joint research institute of the TAMHSC and Texas A&M University – is a co-recipient of a $3.2 million grant from the Environmental Protection Agency and its Science to Achieve Results (STAR) program. The primary objective of the grant is to study current human health risk from chemical exposures.

HSC spin-off company NanoRelease Technologies receives Recovery Act supplement funds for vaccine development training

July 14, 2009

The Texas A&M Health Science Center (HSC) Center for Microencapsulation and Drug Delivery (CMDD) is hosting three students and a science educator who are trainees supported with National Institutes of Health American Recovery and Reinvestment Act funds for vaccine development training.

COM researchers help create new technology to study Salmonella bacterium

July 2, 2009

Researchers at the Texas A&M Health Science Center (HSC) College of Medicine, in collaboration with the Vaccine Research Institute of San Diego, have created a new genetic technology to study Salmonella, a bacterium responsible for approximately 1.4 million cases of food-borne infections in the United States each year.

State gives investment funding to company

July 1, 2009

A Houston-based biotechnology company co-founded by a scientist at the TAMHSC Institute of Biosciences and Technology has received an investment award of $250,000 from the Texas Emerging Technology Fund (TETF).

Sigma Xi symposium addresses “Stem Cells in Medicine” on March 25

March 17, 2009

Co-sponsored by the Texas A&M Health Science Center, the Texas A&M University chapter of Sigma Xi – the national scientific research society – will conduct a one-day symposium called “Stem Cells in Medicine” on March 25.

Governor announces Emerging Technology Fund investment in stem cell research at Texas A&M Health Science Center

February 12, 2009

Governor Rick Perry today announced a $5 million investment through the Texas Emerging Technology Fund (ETF) to recruit leading scientists focused on regenerative medicine technologies to the recently created Texas A&M Health Science Center (HSC) College of Medicine Institute for Regenerative Medicine at Scott & White.

IBT researchers create potential vaccine against dangerous staph infections

December 23, 2008

Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology at Houston have created a vaccine based on the toxin Panton Valentine leukocidin (PVL) to protect mice from deep skin infections and pneumonia associated with a bacteria that are increasingly responsible for serious staph infections.

IBT researchers learn a novel metabolic regulator also suppresses tumors

December 18, 2008

Researchers at the Texas A&M Health Science Center Institute of Biosciences and Technology in Houston have found that a modified specific isotype of the fibroblast growth factor family that is beneficial for prevention of some aspects of metabolic syndrome is also a tumor suppressor.

IBT co-recipient of $7.5 million Komen grant for breast cancer research

December 17, 2008

A five-year, $7.5 million Susan G. Komen for the Cure Promise grant has united research teams at the Texas A&M Health Science Center Institute of Biosciences and Technology and The University of Texas M.D. Anderson to better understand the link between obesity and breast cancer and determine whether clinical intervention in obesity can alleviate breast cancer risk.